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Abstract 
Image fusion software can derive a fusion image from single photon emission computed 
tomography and computed tomography scans. We applied a three-dimensional fusion 
image to detect sentinel lymph nodes (SLNs) in 3 patients with malignant melanomas of 
the lumbar, vulvar and head region, respectively. During each operation, we detected 
SLNs at the expected site, as indicated by the fusion images. The three-dimensional 
image fusion could thus be confirmed as a simple and helpful method for precisely 
localizing SLNs in these patients. 
 
Introduction 
Image fusion software can derive a fusion image from single photon emission 
computed tomography (SPECT) and computed tomography (CT) scans [1–5]. The fusion 
method has the advantage of being cost-effective without the need of special equipment, 
compared to the SPECT/CT system, which is a hybrid imaging method consisting of a 
SPECT camera and a CT scanner combined in a single device. 
Since 2003, fusion images have been used to detect sentinel lymph nodes (SLNs) in 
patients with skin cancer including melanoma, head and neck cancer [4], vulvar [5] and 
prostate [2] cancer, and especially cancer in areas with multiple and varied lymphatic 
drainage patterns or SLNs adjacent to the primary lesion [2]. Here, we report the use of 
three-dimensional (3D) fusion images of SLNs in 3 patients with malignant melanomas in 
the lumbar, vulvar and head region, respectively.  
Case Rep Dermatol 2011;3:74–79 
DOI: 10.1159/000326944 
Published online: 
March 25, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–6567 
www.karger.com/cde 
 
 
75
Case Reports 
Case 1 
A 65-year-old woman was referred to our hospital for the examination of a black, partially erosive 
nodule that had existed for more than 5 years on her median lower back. We diagnosed the lesion as a 
malignant melanoma. Multi-detector computed tomography (MDCT; Light Speed 32; GE Healthcare 
Japan, Tokyo, Japan) and positron emission tomography indicated that there were no metastases of the 
lymph nodes or other organs. One day before the operation, the patient underwent a pre-operative 
lymphoscintigraphy to identify the site of the SLN. A dose of 0.2 ml 14.8 MBq Tc-99m phytate was 
injected intradermally at 4 points around the lesion. A dual-head gamma camera (BrightView; Hitachi 
Medical Corporation/Philips, Tokyo, Japan) produced static images at 15 min and at 2 h after injection. 
The right inguinal basin was shown to contain a hot node. Using an image fusion software (Syntegra; 
Pinnacle; ADAC, Milpitas, Calif., USA), the fusion images were produced based on SPECT and MDCT 
scans after the delayed planar images. To adjust the alignment of both images correctly, we overlapped 
the navel site on the SPECT and MDCT scans. In order to accurately determine the location of the 
regional hot lymph node, we composed the fusion image in 3 views – transaxial, sagittal and coronal 
slices – using an ordered-subset expectation maximization algorithm (Astonish; Philips; fig. 1a). We 
then manipulated the volume rendering function to reconstruct the 3D images (fig. 1b). The hot node 
was clearly evident in the right inguinal basin. It was located anterointernally to the femoral artery and 
vein at the height of the pubic symphysis. Patent blue dye was injected at the tumor site just before the 
operation. The blue dye and the hand-held gamma probe techniques were used in combination during 
the intraoperative SLN mapping. We detected the node at the expected site, as indicated by the 3D 
fusion image.  
Case 2 
A 41-year-old woman presented with an 8-month history of a black nodule on the left labium majus. 
It was a pedunculated lesion with partial erosions and depigmented maculae. An excisional biopsy of 
the tumor revealed a malignant melanoma. The 3D images of the SLN (fig. 2) were obtained in the same 
manner as in Case 1. Hot nodes were present bilaterally in the inguinal basin. The signal intensity was 
hotter in the left than in the right inguinal basin. During the operation, 2 lymph nodes in the left and 1 
in the right inguinal basin were confirmed as SLNs. Each node was harvested from the expected site, as 
indicated by the 3D fusion images. 
Case 3 
A 28-year-old man presented with a 10-year history of a black macule on the right parietal region of 
his head. Three months before the first visit to our hospital, a nodule in the macule was noticed. Biopsy 
findings of the lesion revealed a malignant melanoma. We constructed 3D images of the SLN (fig. 3) in 
the same manner as described in Case 1. To adjust the alignment, 3 markers (capsules with about 7.4 
MBq Tc-99m pertechnetate) were fixed on the glabella, the mentum and the left porus acusticus. Two 
hot nodes were present in the parotid region. During the operation, 2 SLNs were detected. Each node 
was located at the expected site in the parotid gland. 
Discussion 
The SPECT/CT system is reportedly useful for SLN biopsy [6–10]. SPECT detects 
gamma rays and produces the data of radioactive distribution in a 3D format, while CT 
illustrates the anatomical details of a body. Therefore, the SPECT/CT technique can show 
the exact location of SLNs. Wagner et al. [10] reported significant differences (p = 0.0015) 
between the blue dye method only and the SPECT/CT method in detecting the number of 
SLNs in the neck area. van der Ploeg et al. [7] stated that the detailed anatomical  
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information obtained from SPECT/CT was particularly helpful in patients with a 
melanoma in the head and neck. They also showed that in 30 of the 85 (35%) patients 
studied, there were clear advantages of using the SPECT/CT system over conventional 
planar lymphoscintigraphy, which resulted in the surgeons’ altering their incisions [7]. 
In 2003, Kretschmer et al. [1] introduced the fusion of SPECT and pelvic CT scans of 
patients with malignant melanoma of the leg or the lower part of the body. They stated 
that the fusion image was an excellent tool to determine the exact location of pelvic SLNs. 
In 2005, Kizu et al. [2] used SPECT and CT fusion images to detect pelvic SLNs in 
prostate cancer patients. They also concluded that fusion images are useful in precisely 
locating SLNs. While Kizu et al. [2] recognized the usefulness of the SPECT/CT system 
for SLN mapping, they also discussed drawbacks of the system: it is expensive and 
requires extra space for installation. They reported that such drawbacks are not specific to 
the fusion of SPECT and CT images.  
In our patients, the 3D fusion technique provided such concrete images of SLN 
locations in the inguinal and head/neck basin that the surgeons could precisely perform 
an SLN biopsy. Another benefit of the 3D fusion images was that the patients, their 
families and the medical staff could understand the schematic information of the SLN 
sites more easily. Taking into account the reproducibility of patient positioning, the 
fusion technique seems to be well suited especially for patients with melanomas arising 
from the trunk or head, since marking spots adjust for the positional error. Thus, we 
conclude that 3D image fusion was confirmed as a simple and helpful method for 
precisely localizing SLNs in these patients. 
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Fig. 1. 3D fusion images of the SLN in Case 1. a Transaxial, sagittal, and coronal slices of the fusion 
image of the SLN (arrows). b Three-dimensional image of the SLN (arrow) and the tumor site (#). 
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Fig. 2. 3D fusion images of the SLNs in Case 2. The SLNs are denoted with arrows. Note the hotter 
signal in the left inguinal basin compared with the right inguinal basin. The original tumor site is 
depicted as the hottest (#). 
 
 
 
Fig. 3. 3D fusion images of the SLNs in Case 3. a Image demonstrating the SLNs (arrows) and the 
original tumor site (#). b, c Images showing the sagittal slice of the fusion image of the SLN. Levels of 
slices were superficial (b) and deep (c) parotid nodes. Capsules with Tc-99m pertechnetate fixed on the 
glabella and mentum were markers to adjust the alignment. 
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